United States Sulphonamides Market Report 2017

United States Sulphonamides Market Report 2017

  • QYResearch
  • January 2017
  • Pharmaceutical
  • 119 pages

Report Description

1
1
Notes:
Sales, means the sales volume of Sulphonamides
Revenue, means the sales value of Sulphonamides

This report studies sales (consumption) of Sulphonamides in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Split by applications, this report focuses on sales, market share and growth rate of Sulphonamides in each application, can be divided into
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis

Have query on this report?

Make an Enquiry
Table of Contents
United States Sulphonamides Market Report 2017
1 Sulphonamides Overview
1.1 Product Overview and Scope of Sulphonamides
1.2 Classification of Sulphonamides
List of Tables and Figures
Figure Picture of Sulphonamides
Table Classification of Sulphonamides
Figure United States Sales Market Share of Sulphonamides by Type in 2015
Figure Orally Absorbable Sulfonamide Picture
Figure Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Picture

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074